[HTML][HTML] Anemia and inflammatory bowel diseases

F Gomollón, JP Gisbert - World journal of gastroenterology: WJG, 2009 - ncbi.nlm.nih.gov
Too often anemia is considered a rare or unimportant manifestation in inflammatory bowel
disease (IBD). However, over the last 10 years a number of studies have been conducted …

[HTML][HTML] Intravenous iron in inflammatory bowel disease

M Muñoz, S Gómez-Ramírez… - World journal of …, 2009 - ncbi.nlm.nih.gov
The prevalence of anemia across studies on patients with inflammatory bowel disease (IBD)
is high (30%). Both iron deficiency (ID) and anemia of chronic disease contribute most to the …

Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement

JP Gisbert, F Bermejo, R Pajares… - Inflammatory bowel …, 2009 - academic.oup.com
Background The aim was to evaluate the efficacy and tolerance of oral and intravenous iron
treatment in anemic inflammatory bowel disease (IBD) patients, considering both …

[HTML][HTML] Diagnostic considerations in pediatric inflammatory bowel disease management

C Cuffari - Gastroenterology & hepatology, 2009 - ncbi.nlm.nih.gov
Approximately 20% of all inflammatory bowel disease (IBD) first presents in childhood or
adolescence, and approximately 10% of the estimated 1.4 million Americans with IBD are …

[PDF][PDF] Comparative study of efficacy, tolerability and compliance of oral iron preparations (iron edetae, iron polymatose complex) and intramuscular iron sorbitol in iron …

M Afzal, SM Qureshi, M Lutafullah, M Iqbal… - J Pak Med …, 2009 - academia.edu
Objective: To compare the efficacy, tolerability and compliance of oral iron preparations (iron
edetate and Iron polymaltose complex) with each other and with intramuscular iron sorbitol …